 | Stock Traders Purchase High Volume of Sage Therapeutics Call Options (NASDAQ:SAGE)
americanbankingnews.com - January 13 at 2:14 PM |
| Sage Therapeutics, Inc. (NASDAQ:SAGE) to Post FY2026 Earnings of $14.91 Per Share, Piper Sandler Forecasts
americanbankingnews.com - January 13 at 7:20 AM |
 | SAGE Therapeutics Inc (SAGE): Hedge Funds Are Taking Some Chips Off The Table
finance.yahoo.com - January 12 at 5:41 PM |
| Sage Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022
finance.yahoo.com - January 4 at 9:53 AM |
| Sage Therapeutics’ Third Annual FutureCast Showcases Data from All Three Brain Health Franchises
finance.yahoo.com - December 14 at 10:35 AM |
 | Sage Announces Presentation Of Analyses From Clinical Program Of Zuranolone In MDD
nasdaq.com - December 8 at 8:28 AM |
| Sage Therapeutics and Biogen Announce New Analyses from the LANDSCAPE Clinical Development Program of Zuranolone in MDD Presented at the American College of Neuropsychopharmacology (ACNP) Congress
finance.yahoo.com - December 8 at 8:28 AM |
 | Sage Therapeutics - Biogen Share One Year Zuranolone 50mg Data In Depression Patients
msn.com - December 1 at 2:42 PM |
| Sage Announces Positive, One-Year Zuranolone 50 Mg Data On Major Depressive Disorder
nasdaq.com - December 1 at 9:35 AM |
| RSI Alert: Sage Therapeutics (SAGE) Now Oversold
nasdaq.com - November 30 at 2:02 PM |
|
| Sage Therapeutics Inc Shares Close in on 52-Week Low - Market Mover
nasdaq.com - November 30 at 12:17 AM |
| Sage Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
finance.yahoo.com - November 24 at 9:19 AM |
| Declining Stock and Solid Fundamentals: Is The Market Wrong About Sage Therapeutics, Inc. (NASDAQ:SAGE)?
finance.yahoo.com - November 23 at 12:26 PM |
| Emerging Drugs for the Treatment of Postpartum Depression: A Focus on Recent Clinical Trials | DelveInsight
au.finance.yahoo.com - November 23 at 7:25 AM |
 | What 8 Analyst Ratings Have To Say About Sage Therapeutics
benzinga.com - November 4 at 1:11 AM |
| How Bad Are Sage Therapeutics's Earnings? | Return On Capital Employed
benzinga.com - November 2 at 2:12 PM |
| Sage Therapeutics, Inc.'s (NASDAQ:SAGE) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
nasdaq.com - November 2 at 2:12 PM |
| Sage Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
finance.yahoo.com - November 2 at 8:38 AM |
| Should You Buy Sage Therapeutics (SAGE) Ahead of Earnings?
finance.yahoo.com - November 1 at 12:36 PM |
| Sage Therapeutics, Inc. (SAGE) Expected to Beat Earnings Estimates: Should You Buy?
msn.com - October 26 at 9:00 PM |
| The Petri Dish: Sage, Biogen plan drug application; TV show gets FDA nod
finance.yahoo.com - October 21 at 12:40 PM |
| 15 Biotech and Pharmaceutical Stocks to Buy According to Palo Alto Investors
finance.yahoo.com - October 21 at 7:40 AM |
| What 7 Analyst Ratings Have To Say About Sage Therapeutics
benzinga.com - October 20 at 8:54 PM |
| Sage Therapeutics to Report Third Quarter 2021 Financial Results on Tuesday, November 2, 2021
finance.yahoo.com - October 20 at 8:54 PM |
| Sage, Biogen now plan to submit depression drug candidate to FDA in second half of 2022
finance.yahoo.com - October 20 at 10:54 AM |
 | Sage, Biogen To File New Drug Application To FDA For Zuranolone
markets.businessinsider.com - October 19 at 8:47 AM |
 | Sage Therapeutics, Biogen to Seek FDA Approval of Zuranolone in 2nd Half of 2022
marketwatch.com - October 19 at 8:47 AM |
| Should I Buy SAGE Therapeutics Inc (SAGE)?
finance.yahoo.com - October 18 at 5:45 PM |
| Noteworthy Tuesday Option Activity: IHRT, IRBT, SAGE
nasdaq.com - October 6 at 12:35 PM |
| Sage Therapeutics and Biogen Announce Consistent Clinically Meaningful Data for Zuranolone Across the LANDSCAPE and NEST Clinical Development Programs Presented at the European College of Neuropsychopharmacology (ECNP) Congress
finance.yahoo.com - October 4 at 11:30 AM |
| Noema Pharma appoints Jeffrey Jonas as Independent Chairman of the Board of Directors
finance.yahoo.com - October 4 at 6:30 AM |
| Sage Therapeutics Launches SageCitizen Social Impact Initiative
finance.yahoo.com - October 1 at 10:17 AM |
| First Week of May 2022 Options Trading For Sage Therapeutics
nasdaq.com - September 24 at 2:40 PM |
|
| Sage Therapeutics Appoints Chris Benecchi as Chief Commercial Officer
finance.yahoo.com - September 21 at 9:22 AM |
| Why Sage Therapeutics Shares Are Trading Higher Today
msn.com - September 15 at 5:56 PM |
| Sage Therapeutics Gets Fast-Track Designation for Huntington's Disease Treatment
marketwatch.com - September 15 at 7:55 AM |
| Sage Therapeutics Gets Fast Track Designation For SAGE-718 From FDA - Quick Facts
markets.businessinsider.com - September 15 at 7:55 AM |
| Sage Therapeutics Receives Fast Track Designation for SAGE-718 for the Treatment of Huntington’s Disease
finance.yahoo.com - September 15 at 7:55 AM |
| Covid UK news – live: PM says booster vaccines going ahead as advisers set to approve jabs for children
msn.com - September 14 at 10:02 AM |
| Sage Therapeutics (NASDAQ:SAGE) shareholders have endured a 73% loss from investing in the stock three years ago
au.finance.yahoo.com - August 25 at 4:31 PM |
| ESML's Holdings Could Mean 19% Gain Potential
nasdaq.com - August 23 at 9:09 PM |
| Sage Therapeutics Inc (SAGE) Q2 2021 Earnings Call Transcript
finance.yahoo.com - August 11 at 1:28 AM |
| Tuesday 8/10 Insider Buying Report: SAGE, UNVR
nasdaq.com - August 10 at 3:16 PM |
| Sage Therapeutics Inc (SAGE) President and CEO Barry E Greene Bought $1 million of Shares
ca.finance.yahoo.com - August 9 at 6:00 PM |
| Sage Therapeutics Enters Oversold Territory (SAGE)
nasdaq.com - August 6 at 3:13 PM |
| Where Sage Therapeutics Stands With Analysts
markets.businessinsider.com - August 4 at 2:52 PM |
| Sage Therapeutics Drops Two Zuranolone Depression Trials Deemed Unnecessary For Approval
msn.com - August 3 at 1:44 PM |
| Sage Therapeutics' (NASDAQ:SAGE) Shareholders Are Down 71% On Their Shares
nasdaq.com - August 3 at 1:44 PM |
| Sage Therapeutics, Inc. (SAGE) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 3 at 1:44 PM |
| BRIEF-Sage Therapeutics Inc - Now Expects Topline Data For Skylark Study In Mid-2022
msn.com - August 3 at 8:43 AM |
